Ramanathan Madhuri, Luo Wenting, Csóka Balázs, Haskó György, Lukashev Dmitry, Sitkovsky Michail V, Leibovich Samuel Joseph
Department of Cell Biology and Molecular Medicine and The Cardiovascular Research Institute, University of Medicine and Dentistry of New Jersey, Newark, New Jersey 07103, USA.
J Leukoc Biol. 2009 Sep;86(3):681-9. doi: 10.1189/jlb.0109021. Epub 2009 May 28.
Adenosine A(2A)R and TLR agonists synergize to induce an "angiogenic switch" in macrophages, down-regulating TNF-alpha and up-regulating VEGF expression. This switch involves transcriptional regulation of VEGF by HIF-1, transcriptional induction of HIF-1alpha by LPS (TLR4 agonist), and A(2A)R-dependent post-transcriptional regulation of HIF-1alpha stability. Murine HIF-1alpha is expressed as two mRNA isoforms: HIF-1alphaI.1 and -I.2, which contain alternative first exons and promoters. HIF-1alphaI.2 is expressed ubiquitously, and HIF-1alphaI.1 is tissue-specific. We investigated the regulation of these isoforms in macrophages by TLR4 and A(2A)R agonists. HIF-1alphaI.1 is induced strongly compared with HIF-1alphaI.2 upon costimulation with LPS and A(2A)R agonists (NECA or CGS21680). In unstimulated cells, the I.1 isoform constituted approximately 4% of HIF-1alpha transcripts; in LPS and NECA- or CGS21680-treated macrophages, this level was approximately 15%, indicating a substantial contribution of HIF-1alphaI.1 to total HIF-1alpha expression. The promoters of both isoforms were induced by LPS but not enhanced further by NECA, suggesting A(2A)R-mediated post-transcriptional regulation. LPS/NECA-induced expression of HIF-1alphaI.1 was down-regulated by Bay 11-7085 (NF-kappaB inhibitor) and ZM241385 (A(2A)R antagonist). Although VEGF and IL-10 expression by HIF-1alphaI.1-/- macrophages was equivalent to that of wild-type macrophages, TNF-alpha, MIP-1alpha, IL-6, IL-12p40, and IL-1beta expression was significantly greater, suggesting a role for HIF-1alphaI.1 in modulating expression of these cytokines. A(2A)R expression in unstimulated macrophages was low but was induced rapidly by LPS in a NF-kappaB-dependent manner. LPS-induced expression of A(2A)Rs and HIF-1alpha and A(2A)R-dependent HIF-1alpha mRNA and protein stabilization provide mechanisms for the synergistic effects of LPS and A(2A)R agonists on macrophage VEGF expression.
腺苷A(2A)R激动剂与Toll样受体(TLR)激动剂协同作用,诱导巨噬细胞发生“血管生成转换”,下调肿瘤坏死因子-α(TNF-α)并上调血管内皮生长因子(VEGF)表达。这种转换涉及缺氧诱导因子-1(HIF-1)对VEGF的转录调控、脂多糖(LPS,TLR4激动剂)对HIF-1α的转录诱导,以及A(2A)R依赖的HIF-1α稳定性的转录后调控。小鼠HIF-1α以两种mRNA异构体形式表达:HIF-1αI.1和-I.2,它们含有不同的第一个外显子和启动子。HIF-1αI.2在全身广泛表达,而HIF-1αI.1具有组织特异性。我们研究了TLR4和A(2A)R激动剂对巨噬细胞中这些异构体的调控。与HIF-1αI.2相比,在LPS和A(2A)R激动剂(NECA或CGS21680)共同刺激下,HIF-1αI.1的诱导作用更强。在未刺激的细胞中,I.1异构体约占HIF-1α转录本的4%;在LPS以及NECA或CGS21680处理的巨噬细胞中,这一水平约为15%,表明HIF-1αI.1对总HIF-1α表达有显著贡献。两种异构体的启动子均由LPS诱导,但NECA未进一步增强其活性,提示存在A(2A)R介导的转录后调控。LPS/NECA诱导的HIF-1αI.1表达被Bay 11-7085(NF-κB抑制剂)和ZM241385(A(2A)R拮抗剂)下调。尽管HIF-1αI.1基因敲除巨噬细胞中VEGF和白细胞介素-10(IL-10)的表达与野生型巨噬细胞相当,但TNF-α、巨噬细胞炎性蛋白-1α(MIP-1α)、IL-6、IL-12p40和IL-1β的表达显著更高,表明HIF-1αI.1在调节这些细胞因子的表达中发挥作用。未刺激的巨噬细胞中A(2A)R表达较低,但LPS能以NF-κB依赖的方式迅速诱导其表达。LPS诱导A(2A)R表达以及HIF-1α表达,以及A(2A)R依赖的HIF-1α mRNA和蛋白质稳定性,为LPS和A(2A)R激动剂对巨噬细胞VEGF表达的协同作用提供了机制。